Literature DB >> 10432434

Brachytherapy for brain tumor.

J H Suh1, G H Barnett.   

Abstract

Brachytherapy delivers high doses of radiation to brain tumors while sparing normal surrounding tissue. It may be used as a primary treatment, an adjuvant treatment, or as therapy for recurrence of some malignant gliomas, low-grade astrocytomas, meningiomas, metastases, and pediatric brain tumors. Each of the three principal types of brachytherapy (high dose rate, low dose rate, and intracavitary) has advantages and disadvantages. Combining brachytherapy with another modality, such as hyperthermia, may improve results. Although radiosurgery is supplanting brachytherapy for many indications, brachytherapy remains a viable option. This article discusses the radiobiology, procedures, clinical applications, and outcomes of brachytherapy in managing brain tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10432434     DOI: 10.1016/s0889-8588(05)70080-0

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

Review 1.  Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

Authors:  Jeffrey M Craft; Dennis Hallahan
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

2.  Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

Review 3.  Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.

Authors:  Ayal A Aizer; Nayan Lamba; Manmeet S Ahluwalia; Kenneth Aldape; Adrienne Boire; Priscilla K Brastianos; Paul D Brown; D Ross Camidge; Veronica L Chiang; Michael A Davies; Leland S Hu; Raymond Y Huang; Timothy Kaufmann; Priya Kumthekar; Keng Lam; Eudocia Q Lee; Nancy U Lin; Minesh Mehta; Michael Parsons; David A Reardon; Jason Sheehan; Riccardo Soffietti; Hussein Tawbi; Michael Weller; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

4.  Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.

Authors:  Hussam Abou Al-Shaar; Kaith K Almefty; Mohammad Abolfotoh; Nils D Arvold; Phillip M Devlin; David A Reardon; Jay S Loeffler; Ossama Al-Mefty
Journal:  J Neurooncol       Date:  2015-08-08       Impact factor: 4.130

Review 5.  Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?

Authors:  Amanda J Walker; Jake Ruzevick; Ashkan A Malayeri; Daniele Rigamonti; Michael Lim; Kristin J Redmond; Lawrence Kleinberg
Journal:  Future Oncol       Date:  2014-05       Impact factor: 3.404

6.  Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis.

Authors:  Amanda G Linkous; Eugenia M Yazlovitskaya; Dennis E Hallahan
Journal:  J Natl Cancer Inst       Date:  2010-08-20       Impact factor: 13.506

7.  Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.

Authors:  Kwanza T Warren; Andrew Boucher; David P Bray; Sean Dresser; Jim Zhong; Hiu-Kuo Shu; Jeffrey Olson; Kimberly Hoang
Journal:  Cureus       Date:  2021-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.